ERBB2 and breast carcinoma: In contrast, ER-positive breast cancers could be classified into luminal A and luminal B subtypes with significantly distinct prognosis: luminal A tumors displayed favorable outcome, whereas survival of patients with luminal B tumors was poor and comparable with those of the ER-negative ERBB2 and basal subtypes [3].